Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients

Fig. 1

Change in MMD, MHD and MAMI after 3 (M3) and 6 months (M6). A Global mean changes in the entire cohort. B Mean changes by diagnosis at baseline: chronic migraine (CM) or episodic migraine (EM). *p < 0.001. Confidence intervals of 95%. MMD = monthly migraine days; MHD = monthly headache days; MAMI = monthly acute medication intake; SD = standard deviation, M3 = month 3; M6 = month 6; CM = chronic migraine; EM = episodic migraine

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us